Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1
dc.contributor.author | Joo, Nam E. | en_US |
dc.contributor.author | Ritchie, Kathryn | en_US |
dc.contributor.author | Kamarajan, Pachiyappan | en_US |
dc.contributor.author | Miao, Di | en_US |
dc.contributor.author | Kapila, Yvonne L. | en_US |
dc.date.accessioned | 2012-12-11T17:37:36Z | |
dc.date.available | 2014-02-03T16:21:43Z | en_US |
dc.date.issued | 2012-12 | en_US |
dc.identifier.citation | Joo, Nam E.; Ritchie, Kathryn; Kamarajan, Pachiyappan; Miao, Di; Kapila, Yvonne L. (2012). "Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1." Cancer Medicine 1(3): 295-305. <http://hdl.handle.net/2027.42/94527> | en_US |
dc.identifier.issn | 2045-7634 | en_US |
dc.identifier.issn | 2045-7634 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/94527 | |
dc.description.abstract | Nisin, a bacteriocin and commonly used food preservative, may serve as a novel potential therapeutic for treating head and neck squamous cell carcinoma ( HNSCC ), as it induces preferential apoptosis, cell cycle arrest, and reduces cell proliferation in HNSCC cells, compared with primary keratinocytes. Nisin also reduces HNSCC tumorigenesis in vivo. Mechanistically, nisin exerts these effects on HNSCC , in part, through CHAC 1, a proapoptotic cation transport regulator, and through a concomitant CHAC 1‐independent influx of extracellular calcium. In addition, although CHAC 1 is known as an apoptotic mediator, its effects on cancer cell apoptosis have not been examined. Our studies are the first to report CHAC 1's new role in promoting cancer cell apoptosis under nisin treatment. These data support the concept that nisin decreases HNSCC tumorigenesis in vitro and in vivo by inducing increased cell apoptosis and decreased cell proliferation; effects that are mediated by activation of CHAC 1, increased calcium influxes, and induction of cell cycle arrest. These findings support the use of nisin as a potentially novel therapeutic for HNSCC , and as nisin is safe for human consumption and currently used in food preservation, its translation into a clinical setting may be facilitated. Nisin decreases HNSCC tumorigenesis in vitro and in vivo by inducing increased cell apoptosis and decreased cell proliferation; effects that are mediated by activation of CHAC1, increased calcium influxes, and induction of cell cycle arrest. These findings support the use of nisin as a potentially novel therapeutic for HNSCC , and as nisin is safe for human consumption and currently used in food preservation, its translation into a clinical setting may be facilitated. | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Translational Research | en_US |
dc.subject.other | Drug Discovery and Delivery | en_US |
dc.subject.other | Cellular Biology | en_US |
dc.subject.other | Cancer Biology | en_US |
dc.title | Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC 1 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Hematology and Oncology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 23342279 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/94527/1/cam435.pdf | |
dc.identifier.doi | 10.1002/cam4.35 | en_US |
dc.identifier.source | Cancer Medicine | en_US |
dc.identifier.citedreference | Frazer, A. C., M. Sharratt, and J. R. Hickman. 1962. The biological effects of food additives. J. Sci. Food Agric. 13: 32 – 42. | en_US |
dc.identifier.citedreference | Moll, G. N., W. C. Chan, B. W. Bycroft, G. C. Roberts, W. N. Konings, and A. J. Driessen. 1997. Role of transmembrane pH gradient and membrane binding in nisin pore formation. J. Bacteriol. 179: 135 – 140. | en_US |
dc.identifier.citedreference | Wiedemann, I., E. Breukink, C. van Kraaij, O. P. Kuipers, G. Bierbaum, B. de Kruijff, et al. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276: 1772 – 1779. | en_US |
dc.identifier.citedreference | Giffard, C. J., S. Ladha, A. R. Mackie, D. C. Clark, and D. Sanders. 1996. Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching. J. Membr. Biol. 151: 293 – 300. | en_US |
dc.identifier.citedreference | Were, L. M., B. D. Bruce, P. M. Davidson, and J. Weiss. 2003. Size, stability, and entrapment efficiency of phospholipids nanocapsules containing polypeptide antimicrobials. J. Agric. Food Chem. 51: 8073 – 8079. | en_US |
dc.identifier.citedreference | Eckert, R. L. 1989. Structure, function, and differentiation of the keratinoctye. Phys. Rev. 69: 1316 – 1346. | en_US |
dc.identifier.citedreference | Gasparoni, A., L. Fonzi, G. B. Schneider, P. W. Wertz, G. K. Johnson, and C. A. Squier. 2004. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch. Oral Biol. 49: 653 – 664. | en_US |
dc.identifier.citedreference | Ponec, M., J. Kempenaar, and J. Boonstra. 1987. Regulation of lipid synthesis in relation to keratinocyte differentiation capacity. Biochim. Biophys. Acta 921: 512 – 521. | en_US |
dc.identifier.citedreference | Ponec, M., L. Havekes, J. Kempenaar, S. Lavrijsen, and B. J. Vermeer. 1984. Defective low‐density lipoprotein metabolism in cultured, normal, transformed, and malignant keratinocytes. J. Invest. Derm. 83: 436 – 440. | en_US |
dc.identifier.citedreference | Tertoolen, L. G. J., J. Kempenaar, J. Boonstra, S. W. de Laat, and M. Ponec. 1988. Lateral mobility of plasma membrane lipids in normal and transformed keratinoctyes. Biochem. Biophys. Res. Commun. 152: 491 – 496. | en_US |
dc.identifier.citedreference | Tripathi, P., P. Kamarajan, S. S. Bagganahalli, N. MacKinnon, A. M. Chinnaiyan, Y. L. Kapila, et al. 2012. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A 2, a potential therapeutic target. Int. J. Biochem. Cell Biol. 44: 1852 – 1861. | en_US |
dc.identifier.citedreference | Mattson, M., and S. Chan. 2003. Calcium orchestrates apoptosis. Nat. Cell Biol. 5: 1041 – 1043. | en_US |
dc.identifier.citedreference | Mungrue, I. N., J. Pagnon, O. Kohannim, P. S. Gargalovic, and A. J. Lusis. 2009. CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4‐ATF3‐CHOP cascade. J. Immunol. 182: 466 – 476. | en_US |
dc.identifier.citedreference | Baker, M. A., W. L. Molay, M. Zasloff, and L. S. Jacob. 1993. Anticancer efficacy of magainin 2 and analogue peptides. Cancer Res. 53: 3052 – 3057. | en_US |
dc.identifier.citedreference | Hara, S., K. Yakazu, K. Nakakawaji, T. Takeuchi, T. Kobayashi, M. Sata, et al. 1962. An investigation of toxicity of Nisin. Tokyo Med. Univ. J. 20: 176. | en_US |
dc.identifier.citedreference | Pesquera, T. I. 1966. Nisin – its use, estimation and toxicology in sterilized milk. Revita Espanola de Lecheria 5: 25. | en_US |
dc.identifier.citedreference | Alhazzazi, T. Y., P. Kamarajan, N. Joo, J. Y. Huang, E. Verdin, N. J. D'Silva, et al. 2011. Sirtuin‐3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 117: 1670 – 1678. | en_US |
dc.identifier.citedreference | Kamarajan, P., T. Y. Alhazzazi, T. Danciu, N. J. D'silva, E. Verdin, and Y. L. Kapila. 2012. Receptor‐interacting protein (RIP) and Sirtuin‐3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer. doi: 10.1002/cncr.27655. | en_US |
dc.identifier.citedreference | Breukink, E., I. Wiedemann, C. van Kraaij, O. P. Kuipers, H. Sahl, and B. de Kruijff. 1999. Use of the cell wall precursor lipid II by a pore‐forming peptide antibiotic. Science 286: 2361 – 2364. | en_US |
dc.identifier.citedreference | Choi, J., M. K. Lee, O. K. Ho, Y. S. Kim, H. Y. Choi, S. K. Baek, et al. 2011. Interaction effect between the receptor for advanced glycation end products (RAGE) and high‐mobility group box‐1 (HMGB‐1) for the migration of a squamous cell carcinoma cell line. Tumori 97: 196 – 202. | en_US |
dc.identifier.citedreference | Kohn, E. C., E. Reed, E. Sarosy, M. Christian, C. J. Link, K. A. Cole, et al. 1996. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res. 56: 569 – 573. | en_US |
dc.identifier.citedreference | Wu, Y., A. J. Palad, W. J. Wasilenko, P. F. Blackmore, W. A. Pincus, G. L. Schechter, et al. 1997. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido‐triazole. Clin. Cancer Res. 3: 1915 – 1921. | en_US |
dc.identifier.citedreference | Wu, D. M., D. Zhao, D. Z. Li, D. Y. Xu, W. F. Chu, and X. F. Wang. 2011. Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+‐evoked p38 signaling pathway. Naunyn Schmiedebergs Arch. Pharmacol. 383: 321 – 330. | en_US |
dc.identifier.citedreference | Farkas‐Himsley, H., R. Hill, B. Rosen, S. Arab, and C. A. Lingwood. 1995. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc. Natl. Acad. Sci. USA 92: 6996 – 7000. | en_US |
dc.identifier.citedreference | Farkas‐Himsley, H., Y. S. Zhang, M. Yuan, and C. E. Musclow. 1992. Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell death. Cell Mol. Biol. 38: 643 – 651. | en_US |
dc.identifier.citedreference | Sand, S. L., T. M. Haug, J. Nissen‐Meyer, and O. Sand. 2007. The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet. J. Membr. Biol. 216: 61 – 71. | en_US |
dc.identifier.citedreference | Koczulla, A. R., and R. Bals. 2003. Antimicrobial peptides: current status and therapeutic potential. Drugs 63: 389 – 406. | en_US |
dc.identifier.citedreference | Brotz, H., and H.‐G. Sahl. 2000. New insights into the mechanism of action of lantibiotics‐diverse biological effects by binding at the same molecular target. J. Antimicrob. Chemother. 46: 1 – 6. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.